Shoulder Fractures
26
5
5
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
3.8%
1 terminated out of 26 trials
80.0%
-6.5% vs benchmark
12%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (26)
Clinical Decision Rule for Excluding Shoulder Fractures
Zimmer Biomet Shoulder Arthroplasty PMCF
MDR - Comprehensive Primary Revision Stems PMCF
OsseoFit Stemless Shoulder System (Anatomic)
Radiologist-Integrated Finite Element Framework for Acromial Stress in Reverse Shoulder Arthroplasty
Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis
MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
Zimmer Biomet Shoulder Arthroplasty PMCF Study
MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years
Rehabilitation Following Displaced Proximal Humerus Fractures
Management of Proximal Humerus Fractures in Adults: a Clinical Trial
Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP)
Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures
Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term
X-Ray Follow-up in Proximal Humeral Fractures Conservatively Treated
Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery
RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures
A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures
Targon PH+ Follow-Up